BMPR-II Monoclonal Antibody

This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disea

Introducing the BMPR-II Monoclonal Antibody, a cutting-edge product designed to revolutionize the field of biomedical research. This innovative antibody is meticulously crafted to specifically target and bind to the Bone Morphogenetic Protein Receptor II (BMPR-II), a crucial protein involved in various cellular processes.

The BMPR-II Monoclonal Antibody boasts exceptional specificity and affinity, ensuring accurate and reliable results in a wide range of applications. Its high-quality formulation guarantees consistent performance, enabling researchers to confidently explore the intricate mechanisms underlying BMPR-II signaling pathways.

With its advanced technology, this antibody offers unparalleled versatility, making it an indispensable tool for scientists across diverse disciplines. Whether investigating developmental biology, tissue regeneration, or cancer research, the BMPR-II Monoclonal Antibody provides invaluable insights into the intricate workings of cellular processes.

Furthermore, this antibody is meticulously manufactured using state-of-the-art techniques, ensuring exceptional purity and stability. Rigorous quality control measures are implemented throughout the production process, guaranteeing a reliable and reproducible product that meets the highest standards of excellence.

The BMPR-II Monoclonal Antibody is supplied in a convenient and user-friendly format, facilitating seamless integration into various experimental protocols. Its exceptional performance, combined with its ease of use, allows researchers to streamline their workflows and maximize productivity.

In summary, the BMPR-II Monoclonal Antibody represents a groundbreaking advancement in the field of biomedical research. Its exceptional specificity, reliability, and versatility make it an indispensable tool for scientists striving to unravel the complexities of BMPR-II signaling pathways. Embrace this cutting-edge technology and unlock new frontiers in your research endeavors.